Guideline
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Guideline
- Guideline
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022
-
View: 2490 Download: 272 Citations: 6
- KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022
-
DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940
-
View: 5508 Download: 393 Citations: 7
- KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
- Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
- Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021
-
View: 11323 Download: 1,035 Citations: 61
- KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
- Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020
-
View: 15900 Download: 1,196 Citations: 43
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Artificial intelligence in hepatology, Guest editor: Jeong Won Jang, M.D.
- Novel biomarkers for hepatocellular carcinoma, Guest editor: Bo Hyun Kim, M.D.
- Recent update on therapeutics for NAFLD, Guest editor: Won Kim, M.D.
- Interactions between metabolic phenotypes and chronic liver diseases, Guest editor: Dae Won Jun, M.D.
- All about risk models in hepatocellular carcinoma, Guest editor: Ji Hoon Kim, M.D.
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
First decision
09 Days
Publication after acceptance
06 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2021-2023)
|
|||||||
